Evgeniia Bogomol

Title: Evgeniia Bogomol: Innovator in Therapeutic Compounds

Introduction

Evgeniia Bogomol is a prominent inventor based in Kyiv, Ukraine. She has made significant contributions to the field of therapeutic compounds, particularly in the area of androgen receptor modulation. Her innovative work has the potential to impact various medical conditions.

Latest Patents

Evgeniia holds a patent for "Human androgen receptor DNA-binding domain (DBD) compounds as therapeutics and methods for their use." This patent describes a compound with a specific structure that can be utilized in the treatment of androgen-modulated conditions, including various types of cancer, hair loss, acne, hirsutism, ovarian cysts, polycystic ovary disease, precocious puberty, and age-related macular degeneration. The patent outlines the use of these compounds for manufacturing medicaments aimed at modulating androgen receptor activity.

Career Highlights

Evgeniia is affiliated with the University of British Columbia, where she continues her research and development in therapeutic innovations. Her work is characterized by a commitment to advancing medical science through her inventive contributions.

Collaborations

Evgeniia has collaborated with notable colleagues, including Artem Tcherkassov and Paul Rennie. These partnerships have further enriched her research endeavors and expanded the impact of her work.

Conclusion

Evgeniia Bogomol is a trailblazer in the field of therapeutic compounds, with a focus on androgen receptor modulation. Her innovative patent and collaborative efforts highlight her dedication to advancing medical treatments.